MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

March 17, 2022

Study Completion Date

April 15, 2022

Conditions
Pitt Hopkins Syndrome
Interventions
COMBINATION_PRODUCT

vancomycin, magnesium citrate, microbiota

10 days of oral vancomycin, then 1 day of oral magnesium citrate, , then 4 days of high-dose oral microbiota, followed by 12 weeks of low-dose oral microbiota

COMBINATION_PRODUCT

placebo vancomycin, real magnesium citrate, placebo microbiota

10 days of oral placebo vancomycin, then 1 day of oral real magnesium citrate, , then 4 days of high-dose oral placebo microbiota, followed by 12 weeks of low-dose oral placebo microbiota

Trial Locations (1)

85284

Arizona State University, Tempe

All Listed Sponsors
collaborator

Pitt Hopkins Research Foundation

OTHER

lead

Arizona State University

OTHER

NCT04132427 - MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders | Biotech Hunter | Biotech Hunter